{
    "organizations": [],
    "uuid": "cca9c6f22f027cd68b78d5d2c93cdfb5c3bd9bc5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-tesaro-collaborates-with-roche-to/brief-tesaro-collaborates-with-roche-to-evaluate-their-combination-treatment-for-bladder-cancer-idUSFWN1QG19D",
    "ord_in_thread": 0,
    "title": "BRIEF-Tesaro collaborates with Roche to evaluate their combination treatment for bladder cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 26, 2018 / 8:07 PM / Updated 4 minutes ago BRIEF-Tesaro collaborates with Roche to evaluate their combination treatment for bladder cancer Reuters Staff 1 Min Read Feb 26 (Reuters) - Tesaro Inc: * TESARO ANNOUNCES COLLABORATION TO EVALUATE COMBINATION OF ZEJULA® (NIRAPARIB) AND ANTI-PD-L1 CANCER IMMUNOTHERAPY IN METASTATIC BLADDER CANCER * TESARO INC - ‍PLANNED TRIAL WILL BE CONDUCTED BY GENENTECH AND IS EXPECTED TO BEGIN MID-2018​ * TESARO INC - ‍COLLABORATION INCLUDES TESTING EXPERIMENTAL COMBINATION IN MORPHEUS, ROCHE‘S CANCER IMMUNOTHERAPY DEVELOPMENT PLATFORM​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-26T22:05:00.000+02:00",
    "crawled": "2018-02-26T22:24:47.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "collaborates",
        "roche",
        "evaluate",
        "combination",
        "treatment",
        "bladder",
        "cancer",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "tesaro",
        "inc",
        "tesaro",
        "announces",
        "collaboration",
        "evaluate",
        "combination",
        "niraparib",
        "cancer",
        "immunotherapy",
        "metastatic",
        "bladder",
        "cancer",
        "tesaro",
        "inc",
        "trial",
        "conducted",
        "genentech",
        "expected",
        "begin",
        "tesaro",
        "inc",
        "includes",
        "testing",
        "experimental",
        "combination",
        "morpheus",
        "roche",
        "cancer",
        "immunotherapy",
        "development",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}